ICON7
Trial Description:
A randomised, two arm, multi-centre Gynaecologic Cancer InterGroup phase III trial of adding bevacizumab to standard chemotherapy (carboplatin and paclitaxel) in first line treatment of patients with epithelial ovarian cancer.
Lead Cooperative Group:
Participating Groups:
Disease Site:
Ovarian
Trial Status:
Completed
Contact person:
lfarrelly